John Corrin Hutchinson, MD, or “Hutch” to many, professor emeritus and Distinguished Fellow of the American College of Cardiology, passed away peacefully on Jan. 14, 2012. He was 84.
Latest News
December 22, 2011
In a commentary published in the November issue of Academic Medicine, top recruitment experts at UCSF urge academic medical researchers to embrace new methods for recruiting participants into clinical trials.
December 02, 2011
As physicians working on the frontlines of HIV/AIDS since its start 30 years ago near retirement, UCSF is looking to attract and train the next generation of doctors to specialize in HIV/AIDS medicine.
September 29, 2011
It’s a matter of fairness: members of all ethnic groups should have the opportunity to participate in clinical trials. And it’s a matter of soundness, too: medical advancements must be tested in as many different people with as many different genetic makeups as possible.
August 12, 2011
UC scientists explain radiation risks from everyday background radiation, medical imaging and nuclear power plant accidents in the aftermath of meltdowns at the Fukushima Daiichi nuclear power plant in Japan.
May 05, 2011
Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.
March 15, 2011
UCSF is ranked among the nation’s top four schools for medicine and nursing, according to a new survey conducted by U.S. News & World Report.
February 23, 2011
UCSF pediatric endocrinologist Steve Gitelman leads type 1 diabetes clinical trials with the goal of halting beta cell destruction and thereby stopping the progression of disease soon after it is diagnosed.
January 24, 2011
Current legal restrictions significantly compromise the clinical effectiveness of advance directives, according to a study by researchers at the University of California, San Francisco.
December 13, 2010
UCSF physicians are combating a devastating side effect of chemotherapy with an innovative new program -- “Hair to Stay” -- to evaluate devices that could reduce scalp hair loss in breast cancer patients.
